1. Home
  2. TPHS vs NLSP Comparison

TPHS vs NLSP Comparison

Compare TPHS & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPHS
  • NLSP
  • Stock Information
  • Founded
  • TPHS 1959
  • NLSP 2015
  • Country
  • TPHS United States
  • NLSP Switzerland
  • Employees
  • TPHS N/A
  • NLSP N/A
  • Industry
  • TPHS Building operators
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPHS Real Estate
  • NLSP Health Care
  • Exchange
  • TPHS Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • TPHS 7.8M
  • NLSP 8.2M
  • IPO Year
  • TPHS N/A
  • NLSP 2021
  • Fundamental
  • Price
  • TPHS $0.12
  • NLSP $0.20
  • Analyst Decision
  • TPHS
  • NLSP Hold
  • Analyst Count
  • TPHS 0
  • NLSP 1
  • Target Price
  • TPHS N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • TPHS 8.5M
  • NLSP 29.3M
  • Earning Date
  • TPHS 03-30-2023
  • NLSP 07-30-2024
  • Dividend Yield
  • TPHS N/A
  • NLSP N/A
  • EPS Growth
  • TPHS N/A
  • NLSP N/A
  • EPS
  • TPHS N/A
  • NLSP N/A
  • Revenue
  • TPHS $21,231,000.00
  • NLSP N/A
  • Revenue This Year
  • TPHS N/A
  • NLSP N/A
  • Revenue Next Year
  • TPHS N/A
  • NLSP N/A
  • P/E Ratio
  • TPHS N/A
  • NLSP N/A
  • Revenue Growth
  • TPHS N/A
  • NLSP N/A
  • 52 Week Low
  • TPHS $0.08
  • NLSP $0.11
  • 52 Week High
  • TPHS $0.61
  • NLSP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • TPHS 48.54
  • NLSP 55.05
  • Support Level
  • TPHS $0.11
  • NLSP $0.19
  • Resistance Level
  • TPHS $0.13
  • NLSP $0.22
  • Average True Range (ATR)
  • TPHS 0.01
  • NLSP 0.04
  • MACD
  • TPHS 0.00
  • NLSP -0.00
  • Stochastic Oscillator
  • TPHS 52.32
  • NLSP 17.96

About TPHS Trinity Place Holdings Inc.

Trinity Place Holdings Inc is a real estate holding, investment, and asset management company. It is primarily engaged in owning, investing in, managing, developing or redeveloping real estate assets and real estate-related securities. It also controls a range of intellectual property assets focused on the consumer sector, including its online marketplace at FilenesBasement.com, its rights to the Stanley Blacker brand, and the intellectual property associated with the Running of the Brides event. The company generates revenue from Rental revenue, Other Income, and Sales of residential condominium units.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: